We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7936:TSEAsics Corporation Analysis

Data as of 2026-03-13 - not real-time

¥4,460.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ASICS Corp (7936.T) is trading at ¥4,460, which sits just below its 20‑day SMA of ¥4,605 but remains above the 50‑day and 200‑day averages, indicating a mixed short‑term technical picture. The RSI of 51.8 suggests neutral momentum, while a bearish MACD histogram (‑¥53.6) and decreasing volume point to potential near‑term weakness, with the next support around ¥3,955 and resistance at ¥4,964. Despite these signals, the stock benefits from a bullish trend direction flag and a relatively low beta (~0.77), implying modest market sensitivity amid the sector’s cyclical nature.
Fundamentally, ASICS delivers strong growth—revenues rose 21.4% and gross margins stand at 56.8%—and profitability is robust with a 12.2% profit margin and a striking ROE of 38.9%. However, valuation metrics are elevated: a trailing PE of 32, forward PE of 44, and a price‑to‑book of 11.6 contrast sharply with a DCF‑derived fair value of ¥3,357, hinting at overvaluation. The dividend yield is modest at 0.86% with a 20% payout, which appears sustainable given ample cash flow and a solid balance sheet.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and decreasing volume
  • Price near immediate support at ¥3,955
  • High 30‑day volatility (~41%)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (21.4%) and high ROE (38.9%)
  • Upside potential toward analyst median target of ¥5,200
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable brand equity in footwear & accessories
  • Consistent cash generation and low debt leverage
  • Long‑term growth prospects despite current overvaluation

Key Metrics & Analysis

Financial Health

Revenue Growth21.40%
Profit Margin12.17%
P/E Ratio32.3
ROE38.89%
ROA16.11%
Debt/Equity36.05
P/B Ratio11.6
Op. Cash Flow¥109.9B
Free Cash Flow¥71.9B

Technical Analysis

TrendBullish
RSI51.8
Support¥3,955.00
Resistance¥4,964.00
MA 20¥4,605.95
MA 50¥4,199.10
MA 200¥3,868.99
MACDBearish
VolumeDecreasing
Fear & Greed Index73.04

Valuation

Fair Value¥3,356.65
Target Price¥5,150.00
Upside/Downside15.47%
GradeOvervalued
TypeBlend
Dividend Yield0.86%

Risk Assessment

Beta0.77
Volatility40.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.